Rare hereditary autoinflammatory disorders: Towards an understanding of critical in vivo inflammatory pathways

Journal of Dermatological Science

Volumn 66, Issue 3, 2012, Pages 183-189

  Kanazawa, Nobuo ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Hereditary autoinflammatory syndromes; Immunoproteasome; Nakajo Nishimura syndrome; NLRP3 inflammasome; Receptor antagonist

Indexed keywords

CRYOPYRIN; INFLAMMASOME; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 36 RECEPTOR ANTAGONIST; PROTEASOME; UBIQUITIN; UNCLASSIFIED DRUG;

AUTOINFLAMMATORY DISEASE; CAFFEY DISEASE; CELL ACTIVATION; CINCA SYNDROME; CLINICAL FEATURE; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; ENZYME ACTIVATION; ENZYME REGULATION; GENE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC DISORDER; GENETIC IDENTIFICATION; HOMEOSTASIS; HUMAN; IMMUNE DYSREGULATION; IN VIVO STUDY; INBORN ERROR OF METABOLISM; INFLAMMASOMOPATHY; INFLAMMATION; MEFV GENE; MOLECULAR MECHANICS; NAKAJO NISHIMURA SYNDROME; NEUTROPHIL; NLRP3 GENE; OSTEOMYELITIS; PRIORITY JOURNAL; PROTEASOME DISABILITY SYNDROME; PROTEIN FUNCTION; PSMB8 GENE; PUSTULAR PSORIASIS; PUSTULOSIS; RARE DISEASE; RECEPTOR ANTAGONIST DEFICIENCY; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

HEREDITARY AUTOINFLAMMATORY DISEASES; HUMANS; IMMUNITY, INNATE; INFLAMMASOMES; INFLAMMATION; PROTEASOME ENDOPEPTIDASE COMPLEX; RARE DISEASES; RECEPTORS, INTERLEUKIN-1; UBIQUITIN;

EID: 84861344389     PISSN: 09231811     EISSN: 1873569X     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2012.01.004     Document Type: Review

References (50)

1. Kanazawa N., Furukawa F. Autoinflammatory diseases with a dermatological perspective. J Dermatol 2007, 34:601-618.
2. Kastner D.L., Aksentijevich I., Goldbach-Mansky R. Autoinflammatory disease reloaded: a clinical perspective. Cell 2010, 140:784-790.
3. McDermott M.F., Aksentijevich I., Galon J., McDermott E.M., Ogunkolade B.W., Centola M., et al. Germline mutations in the extracellular domains of the 55kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell 1999, 97:133-144.
4. French FMF Consortium A candidate gene for familial Mediterranean fever. Nat Genet 1997, 17:25-31.
5. The International FMF Consortium Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell 1997, 90:797-807.
6. Hoffman H.M., Mueller J.L., Broide D.H., Wanderer A.A., Kolodner R.D. Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat Genet 2001, 29:301-305.
7. Agostini L., Martinon F., Burns K., McDermott M.F., Hawkins P.N., Tschopp J. NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity 2004, 20:319-325.
8. Dowds T.A., Masumoto J., Chen F.F., Ogura Y., Inohara N., Nunez G. Regulation of cryopyrin/Pypaf1 signaling by pyrin, the familial Mediterranean fever gene product. Biochem Biophys Res Commun 2003, 302:575-580.
9. Chae J.J., Wood G., Masters S.L., Richard K., Park G., Smith B.J., et al. The B30.2 domain of pyrin, the familial Mediterranean fever protein, interacts directly with caspase-1 to modulate IL-1beta production. Proc Natl Acad Sci U S A 2006, 103:9982-9987.
10. Papin S., Cuenin S., Agostini L., Martinon F., Werner S., Beer H.D., et al. The SPRY domain of pyrin, mutated in familial Mediterranean fever patients, interacts with inflammasome components and inhibits proIL-1beta processing. Cell Death Differ 2007, 14:1457-1466.
11. Masters S.L., Simon A., Aksentijevich I., Kastner D.L. Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease. Annu Rev Immunol 2009, 27:621-668.
12. Tanaka N., Izawa K., Saito M.K., Sakuma M., Oshima K., Ohara O., et al. High incidence of NLRP3 somatic mosaicism in patients with chronic infantile neurologic, cutaneous, articular syndrome: results of an international multicenter collaborative study. Arthritis Rheum 2011, 63:3625-3632.
13. Aksentijevich I., Masters S.L., Ferguson P.J., Dancey P., Frenkel J., van Royen-Kerkhoff A., et al. An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist. N Engl J Med 2009, 360:2426-2437.
14. Reddy S., Jia S., Geoffrey R., Lorier R., Suchi M., Broeckel U., et al. An autoinflammatory disease due to homozygous deletion of the IL1RN locus. N Engl J Med 2009, 360:2438-2444.
15. Marrakchi S., Guigue P., Renshaw B.R., Puel A., Pei X.Y., Fraitag S., et al. Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis. N Engl J Med 2011, 365:620-628.
16. Arima K., Kinoshita A., Mishima H., Kanazawa N., Kaneko T., Mizushima T., et al. Proteasome assembly defect due to a proteasome subunit beta type 8 (PSMB8) mutation causes the autoinflammatory disorder, Nakajo-Nishimura syndrome. Proc Natl Acad Sci U S A 2011, 108:14914-14919.
17. Kitamura A., Maekawa Y., Uehara H., Izumi K., Kawachi I., Nishizawa M., et al. A mutation in the immunoproteasome subunit PSMB8 causes autoinflammation and lipodystrophy in humans. J Clin Invest 2011, 121:4150-4160.
18. Agarwal A.K., Xing C., DeMartino G.N., Mizrachi D., Hernandez M.D., Sousa A.B., et al. PSMB8 encoding the β5i proteasome subunit is mutated in joint contractures, muscle atrophy, microcytic anemia, and panniculitis-induced lipodystrophy syndrome. Am J Hum Genet 2010, 87:866-872.
19. Liu Y, Ramot Y, Torrelo A, Paller AS, Si N, Babay S, et al. Mutations in PSMB8 cause CANDLE syndrome with evidence of genetic and phenotypic heterogeneity. Arthritis Rheum; , in press. doi:10.1002/art.33368.
20. Kile R.L., Rusk H.A. A case of cold urticaria with unusual family history. JAMA 1940, 114:1067-1068.
21. Muckle T.J., Wells M. Urticaria, deafness and amyloidosis: a new heredo-familial syndrome. Quart J Med 1962, 31:235-248.
22. Kastner D.L., O'Shea J.J. A fever gene comes in from the cold. Nat Genet 2001, 29:241-242.
23. Feldmann J., Prieur A.M., Quartier P., Berquin P., Certain S., Cortis E., et al. Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes. Am J Hum Genet 2002, 71:198-203.
24. Aksentijevich I., Nowak M., Mallah M., Chae J.J., Watford W.T., Hofmann S.R., et al. De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases. Arthritis Rheum 2002, 46:3340-3348.
25. Arostegui J.I., Aldea A., Modesto C., Rua M.J., Arguelles F., González-Enseñat M.A., et al. Clinical and genetic heterogeneity among Spanish patients with recurrent autoinflammatory syndromes associated with the CIAS1/PYPAF1/NALP3 gene. Arthritis Rheum 2004, 50:4045-4050.
26. McDermott M.F., Tschopp J. From inflammasomes to fevers, crystals and hypertension: how basic research explains inflammatory diseases. Trends Mol Med 2007, 13:381-388.
27. Nakamura Y., Kambe N., Saito M., Nishikomori R., Kim Y.G., Murakami M., et al. Mast cells mediate neutrophil recruitment and vascular leakage through the NLRP3 inflammasome in histamine-independent urticaria. J Exp Med 2009, 206:1037-1046.
28. Hoffman H.M., Rosengren S., Boyle D.L., Cho J.Y., Nayar J., Mueller J.L., et al. Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist. Lancet 2004, 364:1779-1785.
29. Hoffman H.M., Throne M.L., Amar N.J., Sebai M., Kivitz A.J., Kavanaugh A., et al. Efficacy and safety of rilonacept (interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes: results from two sequential placebo-controlled studies. Arthritis Rheum 2008, 58:2443-2452.
30. Lachmann H.J., Lowe P., Felix S.D., Rordorf C., Leslie K., Madhoo S., et al. In vivo regulation of interleukin 1beta in patients with cryopyrin-associated periodic syndromes. J Exp Med 2009, 206:1029-1036.
31. Kanneganti T.D., Ozoren N., Body-Malapel M., Amer A., Park J.H., Franchi L., et al. Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3. Nature 2006, 440:233-236.
32. Yu J.W., Wu J., Zhang Z., Datta P., Ibrahimi I., Taniguchi S., et al. Cryopyrin and pyrin activate caspase-1, but not NF-kappaB, via ASC oligomerization. Cell Death Differ 2006, 13:236-249.
33. Chae J.J., Komarow H.D., Cheng J., Wood G., Raben N., Liu P.P., et al. Targeted disruption of pyrin, the FMF protein, causes heightened sensitivity to endotoxin and a defect in macrophage apoptosis. Mol Cell 2003, 11:591-604.
34. Chae J.J., Cho Y.H., Lee G.S., Cheng J., Liu P.P., Feigenbaum L., et al. Gain-of-function Pyrin mutations induce NLRP3 protein-independent interleukin-1β activation and severe autoinflammation in mice. Immunity 2011, 34:755-768.
35. Lindor N.M., Arsenault T.M., Solomon H., Seidman C.E., McEvoy M.T. A new autosomal dominat disorder of pyogenic sterile arthritis, pyoderma gangrenosum, and acne: PAPA syndrome. Mayo Clin Proc 1997, 72:611-615.
36. Wise C.A., Bennett L.B., Pascual V., Gillum J.D., Bowcock A.M. Localization of a gene for familial recurrent arthritis. Arthritis Rheum 2000, 43:2041-2045.
37. Wise C.A., Gillum J.D., Seidman C.E., Lindor N.M., Veile R., Bashiardes S., et al. Mutations in CD2BP1 disrupt binding to PTP PEST and are responsible for PAPA syndrome, an autinflammatory disorder. Hum Mol Genet 2002, 22:961-969.
38. Shoham N.G., Centola M., Mansfield E., Hull K.M., Wood G., Wise C.A., et al. Pyrin binds the PSTPIP1/CD2BP1 protein, defining familial Mediterranean fever and PAPA syndrome as disorders in the same pathway. Proc Natl Acad Sci U S A 2003, 100:13501-13506.
39. Brenner M., Ruzicka T., Plewig G., Thomas P., Herzer P. Targeted treatment of pyoderma gangrenosum in PAPA (pyogenic arthritis, pyoderma gangrenosum and acne) syndrome with the recombinant human interleukin-1 receptor antagonist anakinra. Br J Dermatol 2009, 161:1199-1201.
40. Braun-Falco M, Kovnerystyy O, Lohse P, Ruzicka T. Pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH)-a new autoinflammatory syndrome distinct from PAPA syndrome. J Am Acad Dermatol; , in press. doi:10.1016/j.bbr.2011.03.031.
41. Leung V.C., Lee K.E. Infantile cortical hyperostosis with intramedullary lesions. J Pediatr Orthop 1985, 5:354-357.
42. Ivker R.A., Grin-Jorgensen C.M., Vega V.K., Hoss D.M., Grant-Kels J.M. Infantile generalized pustular psoriasis associated with lytic lesions of the bone. Pediatr Dermatol 1993, 10:277-282.
43. Dinallero C.A. Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol 2009, 27:519-550.
44. Horai R., Saijo S., Tanioka H., Nakae S., Sudo K., Okahara A., et al. Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice. J Exp Med 2000, 191:313-320.
45. Dinarello C., Arend W., Sims J., Smith D., Blumberg H., O'Neill L., et al. IL-1 family nomenclature. Nat Immunol 2010, 11:973.
46. Kitano Y., Matsunaga E., Morimoto T., Okada N., Sano S. A syndrome with nodular erythema, elongated and thickened fingers, and emaciation. Arch Dermatol 1985, 121:1053-1056.
47. Tanaka M., Miyatani N., Yamada S., Miyashita K., Toyoshima I., Sakuma K., et al. Hereditary lipo-muscular atrophy with joint contracture, skin eruptions and hyper-gamma-globulinemia: a new syndrome. Intern Med 1993, 32:42-45.
48. Garg A., Hernandez M.D., Sousa A.B., Subramanyam L., Martinez de Villarreal L., et al. An autosomal recessive syndrome of joint contracture, muscular atrophy, microcytic anemia, and panniculitis-associated lipodystrophy. J Clin Endocrinol Metab 2010, 95:E48-E63.
49. Torrelo A., Patel S., Colmenero I., Gurbindo D., Lendínez F., Hernández A., et al. Chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature (CANDLE) syndrome. J Am Acad Dermatol 2010, 62:489-495.
50. Ramot Y., Czarnowicki T., Maly A., Navon-Elkan P., Zlotogorski A. Chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature syndrome: a case report. Pediatric Dermatol 2011, 28:538-541.